Gynecologic Cancers Features Archive

Is BRCA1/2 Genetic Counseling by Telephone Inferior to a Face-to-face Interaction?

Is BRCA1/2 Genetic Counseling by Telephone Inferior to a Face-to-face Interaction?

Telephone interviews to deliver genetic counseling may be non-inferior to in-person counseling.

Multi-gene Testing Increases Complexity of Counseling Women at Risk of Breast and Ovarian Cancer

Multi-gene Testing Increases Complexity of Counseling Women at Risk of Breast and Ovarian Cancer

Data sharing and increased pools of data are promising for prevention and early diagnosis of breast cancer and ovarian cancer.

ASCO Issues New Guidelines Regarding Health Care Access for Patients With Invasive Cervical Cancer

ASCO Issues New Guidelines Regarding Health Care Access for Patients With Invasive Cervical Cancer

New guidelines provide clinical practice recommendations for patients with cervical cancer in regions with "basic, limited, enhanced, and maximal" health care resources.

BRCA1 Germline Mutation Associated With Reduced Ovarian Reserve

BRCA1 Germline Mutation Associated With Reduced Ovarian Reserve

Study results show that women who carry a BRCA1 mutation have a shorter reproductive lifespan than noncarriers.

Farletuzumab Shows Limited Efficacy in Relapsed Ovarian Cancer

Farletuzumab Shows Limited Efficacy in Relapsed Ovarian Cancer

Farletuzumab, did not meet its primary endpoint in first platinum-sensitive relapse of ovarian cancer. But in a subset of patients, risk of progression was significantly reduced.

Paradigm Shift in Ovarian Cancer Points to Fallopian Tube as Site of Origin

Paradigm Shift in Ovarian Cancer Points to Fallopian Tube as Site of Origin

The decade-long paradigm shift in decoding ovarian cancer is only now beginning to make its way from research journals into clinical practice.

Co-testing May Detect Invasive Cervical Cancer Better Than HPV-only Screening

Co-testing May Detect Invasive Cervical Cancer Better Than HPV-only Screening

Not only may co-testing help detect more cases of invasive cervical cancer, but it also may lower overall health care costs.

ACOG Recommends Primary HPV Screening as Alternative to Cytology in Those 25 Years and Older

ACOG Recommends Primary HPV Screening as Alternative to Cytology in Those 25 Years and Older

New guidelines stated that screening with an FDA-approved primary HPV test could substitute cytology-based cervical cancer screening methods.

Bevacizumab Not Beneficial in Subset of Cervical Cancer Patients

Bevacizumab Not Beneficial in Subset of Cervical Cancer Patients

By identifying patients with cervical cancer as low, intermediate, or high-risk, physicians can determine whether bevacizumab will provide survival benefit.

Study Links Oral Contraceptive Use to Better Ovarian Cancer Outcomes

Study Links Oral Contraceptive Use to Better Ovarian Cancer Outcomes

Ovarian cancer may progress more slowly in women who once used oral contraceptives (OCs).

Adjuvant Hormonal Therapy Is Safe in Epithelial Ovarian Cancer

Adjuvant Hormonal Therapy Is Safe in Epithelial Ovarian Cancer

Pre- or postmenopausal women with epithelial ovarian cancer can safely be treated with adjuvant hormone therapy.

Beta-blockers May Help Prolong Survival in Ovarian Cancer Patients

Beta-blockers May Help Prolong Survival in Ovarian Cancer Patients

A retrospective study showed improved survival among patients with ovarian cancer treated with beta-blockers.

Multigene Panel Testing for Breast, Ovarian Cancer Clinically Valuable

Multigene Panel Testing for Breast, Ovarian Cancer Clinically Valuable

Multigene panel testing can identify mutations that warrant management changes in patients who lack BRCA1 and 2.

IP Chemotherapy Improves Survival in Advanced Ovarian Cancer, But Questions Remain

IP Chemotherapy Improves Survival in Advanced Ovarian Cancer, But Questions Remain

Treatment of ovarian cancer with IP chemo resulted in significant improvement in survival, but benefit could be explained by clinical factors.

Nomograms Predict Locally Advanced Cervical Cancer Recurrence, Patient Survival

Nomograms Predict Locally Advanced Cervical Cancer Recurrence, Patient Survival

Newly validated nomograms were more prognostic of patient survival from cervical cancer than cancer stage.

Biomarkers of HIV-associated Cancer

Biomarkers of HIV-associated Cancer

[Biomark Cancer] Biomarkers can provide great opportunities in the management of the most common HIV-associated malignancies, namely, Kaposi sarcoma, non-Hodgkin's lymphoma, and invasive cervical cancer.

Human Papillomavirus (HPV) Test May Be More Accurate Than Pap Test for Cervical Cancer Screening

Human Papillomavirus (HPV) Test May Be More Accurate Than Pap Test for Cervical Cancer Screening

A review of data suggests that HPV testing alone every 3 years provides a high level of reassurance against cervical cancer.

Cervical Cancer Rates May Be Higher in Older Women Than Previously Reported

Cervical Cancer Rates May Be Higher in Older Women Than Previously Reported

Rate of cervical cancer in African-American women is higher than what was previously recognized.

Secondary Colorectal Cancer Tied to Radiation-treated Cervical Cancer

Secondary Colorectal Cancer Tied to Radiation-treated Cervical Cancer

New colorectal cancer surveillance strategies are warranted in cervical cancer survivors who have been treated with radiotherapy.

Veliparib May Benefit Women With Treatment-resistant Gynecologic Cancers

Veliparib May Benefit Women With Treatment-resistant Gynecologic Cancers

The PARP inhibitor veliparib shows promise in women with BRCA-mutated gynecologic cancers that have not responded to previous treatments.

Women With BRCA Mutations Shouldn't Delay Oophorectomy

Women With BRCA Mutations Shouldn't Delay Oophorectomy

For women with a BRCA mutation, delaying oophorectomy beyond age 35 sharply increases the risk of cancer and mortality.

New Study May Pave Way for Detecting Ovarian Cancer Earlier

New Study May Pave Way for Detecting Ovarian Cancer Earlier

Research has revealed new genetic variants in patients with ovarian cancer that may eventually help detect the disease earlier.

Bevacizumab Plus Chemo Prolongs Survival in Advanced Cervical Cancer

Bevacizumab Plus Chemo Prolongs Survival in Advanced Cervical Cancer

Patients given bevacizumab survived almost 4 months longer than controls, but had a higher rate of adverse events.

Reprogramming Ovarian Cancer Cells Boosts Recognition by Immune System

Reprogramming Ovarian Cancer Cells Boosts Recognition by Immune System

Researchers have discovered a novel approach to making ovarian tumor cells more visible to anticancer therapy.

ASCO's Clinical Cancer Advances 2013 Highlights Genomic Research, Targeted Therapy

ASCO's Clinical Cancer Advances 2013 Highlights Genomic Research, Targeted Therapy

Great strides have been made in cancer research this year, including targeted therapies that may soon be used as a standard of care.

One Dose of HPV Vaccine May Prevent Infection

One Dose of HPV Vaccine May Prevent Infection

A new study reveals that the HPV vaccine generates longer-term immune responses than previously thought.

Cervical Cancer Screening Recommendations: Evolving Norms

Cervical Cancer Screening Recommendations: Evolving Norms

Emerging screening technologies and strategies are being added to the cervical cancer prevention arsenal.

Targeted Therapies May Improve Survival in Patients with Ovarian Cancer

Targeted Therapies May Improve Survival in Patients with Ovarian Cancer

New cancer therapies and statins demonstrate efficacy in treating and perhaps even preventing ovarian cancer recurrence.

High Serum Calcium May Indicate Preclinical Ovarian Cancer

High Serum Calcium May Indicate Preclinical Ovarian Cancer

A preliminary study finds that rising serum calcium levels may detect ovarian cancer at a preclinical stage.

Ovarian Cancer: To Screen or Not to Screen?

Ovarian Cancer: To Screen or Not to Screen?

Screening healthy women for ovarian cancer may do more harm than good, but is it a risk some patients may be willing to take for peace of mind?

Current and Emerging Cervical Cancer Screening Guidelines and Tools

Current and Emerging Cervical Cancer Screening Guidelines and Tools

Improved screening practices, preventative immunizations, and timely treatment of invasive disease can help reduce the number of deaths due to cervical cancer.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs